Exclusive

Publication

Byline

Location

Tata Capital IPO subscription reaches $1 billion - Is it worth investing?

India, Oct. 7 -- The Tata Capital IPO attracted a subscription worth $1 billion (about Rs.8,871 crore) by the first day of the share sale, but the anchor book accounts for half of that. India's large... Read More


Donald Trump announces 25% tariff on all truck imports from November 1

India, Oct. 6 -- The US will impose a 25% tariff on imports of all medium and heavy-duty trucks, President Donald Trump announced on Truth Social on Monday. "Beginning November 1st, 2025, all medium ... Read More


Donald Trump announces 25% tariff on all imported trucks from November 1

India, Oct. 6 -- The United States will impose a 25% tariff on all medium and heavy-duty trucks, President Donald Trump announced on Truth Social on Monday. "Beginning November 1st, 2025, all medium ... Read More


Tata Capital GMP points to cautious optimism even as India's biggest IPO of 2025 opens

India, Oct. 6 -- Investors have turned cautious on demand for unlisted shares of Tata Capital Ltd. in the unregulated market, even as India's biggest IPO of 2025 opens for subscription today. The Tat... Read More


OpenAI, Jony Ive battle critical problems that can delay AI device launch

India, Oct. 6 -- An AI device that OpenAI is developing with star designer Jony Ive is faced with critical problems that may delay a launch planned for next year, the Financial Times reported on Monda... Read More


Lenskart gets SEBI approval to launch rRs.r2,150-crore IPO in India

India, Oct. 6 -- Lenskart, which is poised to become India's first eyewear-only company to go public, has received approval for a stock market listing, the markets regulator said on Monday. Lenskart ... Read More


Mounjaro maker Eli Lilly charts billion-dollar India investment plan amid 100% US tariff on pharma

India, Oct. 6 -- Eli Lilly & Co., the maker of the blockbuster Mounjaro diabetes drug, plans to invest more than $1 billion for contract manufacturing in India, amid 100% US tariff on the pharma secto... Read More


Mounjaro maker Eli Lilly charts billion-dollar India plan amid 100% US tariff on pharma

India, Oct. 6 -- Eli Lilly & Co., the maker of the blockbuster Mounjaro diabetes drug, plans to invest more than $1 billion for contract manufacturing in India, amid 100% US tariff on the pharma secto... Read More


Sammaan Capital to sell billion-dollar stake to Abu Dhabi's biggest listed company

India, Oct. 3 -- Sammaan Capital Ltd. has decided to sell a billion-dollar stake to Abu Dhabi's biggest listed company, a move that sent its share price crashing on Friday. International Holding Co. ... Read More


TCS is first among peers to face investors amid H-1B visa shock, AI-led layoffs

India, Oct. 3 -- A week from now, Tata Consultancy Services Ltd. will become the first Indian IT firm to face investors after an H-1B sticker shock and AI layoffs. TCS will report its second-quarter ... Read More